ecrin-mdr-crcClinical2020Colorectal CancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2691909China5ECRIN MDRNot yet recruitingfalsePhase II clinical study of advanced PMMR colorectal cancer treated by cindilimab and regofinib combinating radiotherapy and Stereotactic therapyInterventions: Case series:Sintilimab and Regorafenib plus Stereotactic Radiotherapy Primary outcome(s): Overall survival, OS Study Design: Single arm2020-05-152691909ChiCTR2000031237